NKGen Biotech Publishes Phase 1 Interim Analysis Results of SNK02 Allogeneic NK Cell Therapy in Advanced Solid Tumors at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

8d ago

NKGN

PremiumPress Releases

NKGen Biotech’s SNK01 NK Cell Therapy Cleared to Start Phase 2 Clinical Trial in Alzheimer’s Disease

12d ago

NKGN

PremiumPress Releases

NKGen Biotech Announces Upcoming Presentation on Autologous NK Cell Therapy at the 5th International Cell & Gene Therapy China Summit & Exhibition

16d ago

NKGN

PremiumPress Releases

NKGen Biotech Presents Updated NK Cell Therapy Data for Neurodegenerative Disease at the 12th Annual Alzheimer’s & Parkinson’s Drug Development Summit

1M ago

NKGN

PremiumPress Releases

NKGen Biotech Announces Upcoming Publication at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

1M ago

NKGN

PremiumPress Releases

NKGen Biotech Announces Upcoming Presentation on SNK01 NK Cell Therapy in Neurodegenerative Disease at the 12th Annual Alzheimer’s & Parkinson’s Drug Development Summit

1M ago

NKGN

PremiumCompany Announcements

NKGen Biotech Secures $5M in Strategic Financing Deal

2M ago

NKGN

More NKGN News >

NKGN News on the Web

2024-05-23

NKGen Biotech Publishes Phase 1 Interim Analysis Results of SNK02 Allogeneic NK Cell Therapy in Advanced Solid Tumors at the 2024 American Society of Clinical Oncology Annual Meeting

Yahoo Finance

Neutral

2024-05-21

NKGN Stock Earnings: NKGen Biotech Reported Results for Q1 2024

InvestorPlace

Neutral

2024-05-20

NKGN Stock Alert: The Alzheimer’s News That Has NKGen Biotech Soaring Today

InvestorPlace

Bullish

2024-05-20

NKGen Biotech’s SNK01 NK Cell Therapy Cleared to Start Phase 2 Clinical Trial in Alzheimer’s Disease

Yahoo Finance

Neutral

2024-04-29

NKGen Biotech: FDA Clears IND Application For SNK01 NK Cell Therapy - Quick Facts

rttnews

Neutral

2024-04-29

NKGen Biotech Announces FDA Clearance of Investigational New Drug Application for SNK01 NK Cell Therapy in Parkinson’s Disease

Yahoo Finance

Neutral

2024-04-25

NKGen Biotech Presents Updated NK Cell Therapy Data for Neurodegenerative Disease at the 12th Annual Alzheimer’s & Parkinson’s Drug Development Summit

Yahoo Finance

Neutral

2024-04-24

NKGen Biotech Announces Upcoming Publication at the 2024 American Society of Clinical Oncology Annual Meeting

Yahoo Finance

Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

Currently, no data available

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is NKGN’s Media Buzz Sentiment?

Currently, no data Available

What is NKGN’s weekly average amount of articles?

Currently, no data Available

What is NKGN’s News Sentiment?

Currently, no data Available

Healthcare Stocks that are Trending in the News

LNTHLantheus

50JKangji Medical Holdings Limited

INSMInsmed

PG3Probiotec Limited

SAGESAGE Therapeutics

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing